More articles from Oncology, Clinical Science Track

You have access
Solitary cystic neck lesion: which FDG-PET/CT imaging parameter identifies malignancy?
Anders Thomassen, Pey Abadi, Oke Gerke, Christian Godballe and Poul Flemming Hoilund-Carlsen

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1582;
You have access
Combination of 18F-FDG PET/CT texture features with dynamic contrast-enhanced and diffusion-weighted MRI parameters for the prediction of prognosis in patients with primary oropharyngeal or hypopharyngeal squamous cell carcinoma
Sheng-Chieh Chan, Shu-Hang Ng and Hung- Ming Wang

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1581;
You have access
Comparative assessment of skeletal uptake on Ga-68 PSMA PET/CT versus F-18 Fluoride PET/CT in metastatic prostate cancer
AVIRAL SINGH, Harshad Kulkarni, Karin Niepsch and Richard Baum

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1543;
You have access
Evaluation of clinicopathological and risk factors in advanced colorectal neoplasm incidentally detected by FDG PET/CT
Ihn Ho Cho, EunJung Kong, KyungAh Chun, SeungMin Chung, KyungOk Kim and TaeNyeun Kim

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1590;
You have access
Prospective Comparison of 11C-4DST, 18F-FDG PET/CT and whole-body MRI in the patients with multiple myeloma
Ryogo Minamimoto, Jun Toyohara, Momoko Okasaki, Miyako Morooka, Yoko Miyata, Masashi Kameyama, Masatoshi Hotta, Kazuhiko Nakajima, Akiyoshi Miwa and Kazuo Kubota

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1610;
You have access
A retrospective comparative study of sodium fluoride (NaF-18)-PET/CT and fluorocholine (F-18-CH) PET/CT in the evaluation skeletal metastases in metastatic prostate cancer using a volumetric 3-D analysis
Kalevi Kairemo, Timo Joensuu, Srinivas Kappadath and Homer Macapinlac

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1553;
You have access
Response assessment to treatment with Lu-177 labeled PSMA inhibitor in patients with metastatic castration-resistant prostate cancer: differential response of bone versus lymph node lesions
Harshad Kulkarni, AVIRAL SINGH and Richard Baum

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1547;
You have access
The role of interim 18F-FDG PET/CT in DLBCL patients: SUV max, SUV mean and SUV peak as predictive metabolic parameters of prognosis
Lucia Baratto, Fengyu Wu, Ryogo Minamimoto, Jean Sabile, Ranjana Advani and Erik Mittra

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1615;
You have access
F-18 FDG PET/CT for the diagnosis of lymphoma and analysis on misdiagnosis
Hui-Chun Wang and Yu-Bin Wang

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1622;
You have access
18F-FDG PET/CT in the follow-up of asymptomatic RCC patients after surgery : Can substitute conventional imaging?
Sohyun Park, Ho-Young Lee and Sang Eun Kim

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1564;

Main menu

User menu

Search

More articles from Oncology, Clinical Science Track

Pages